New CEO appointed for NHS Supply Chain

28 July 2021
  • Andrew New has been appointed as the new Chief Executive Officer for NHS Supply Chain
  • Andrew will commence his new role on 1 September 2021
  • Andrew joins NHS Supply Chain from JCB where he held the position of Group Executive Director, Purchasing and Supply Chain.

Following an external fair and open recruitment campaign, Andrew New has been appointed as the new Chief Executive Officer for NHS Supply Chain. Andrew will commence his new role on 1 September. He joins NHS Supply Chain from JCB where he held the position of Group Executive Director, Purchasing and Supply Chain.  Previous to that he has held senior procurement and supply chain roles for Magnox (a subsidiary of the NDA) and Babcock International Group. 

CEO Andrew New

Commenting on his appointment, Andrew said: “I am delighted to be joining SCCL as NHS Supply Chain’s CEO at this critical time. NHS Supply Chain makes such an important contribution to the NHS and I am looking forward to meeting with colleagues, service providers, customers, suppliers and stakeholders to understand current challenges but also to continue to drive performance and establish a future world-class supply chain that meets the changing needs of the NHS.”

Jim Spittle, Chair, Supply Chain Coordination Limited, the management function of NHS Supply Chain said: “I am pleased to welcome Andrew as the newly appointed CEO of NHS Supply Chain who joins the team at a critical time in our transformation journey. Andrew brings with him considerable experience within the Supply Chain sector which will benefit us and our customers. I know he’ll make a huge impact at this pivotal time.”

The board of SCCL would like to extend our appreciation to Colin McCready, acting CEO, who delivered exceptional results whilst in post. Colin will revert to his role as Chief Financial Officer, NHS Supply Chain, following an appropriate hand-over to Andrew.

Media Enquiries:

Jo Travis

Communications Consultant

About NHS Supply Chain

All information in this press release is correct at the time of going to press.

NHS Supply Chain manages the sourcing, delivery and supply of healthcare products, services and food for NHS trusts and healthcare organisations across England and Wales.

Managing more than 4.5 million orders per year, across 94,000 order points and 15,000 locations, NHS Supply Chain systems consolidate orders from over 800 suppliers, saving trusts time and money and removing duplication of overlapping contracts. 

Lord Carter’s report into efficiency and productivity in the NHS, published in 2015, identified unwarranted variation in procurement across the NHS, resulting in the need to improve operational efficiencies to transform a fragmented procurement landscape. To undertake this transformation the Department of Health and Social Care established the Procurement Transformation Programme (PTP) to deliver a new NHS Supply Chain.

The new NHS Supply Chain was designed to help the NHS deliver clinically assured, quality products at the best value, through a range of specialist buying functions. Its aim is to leverage the buying power of the NHS to negotiate the best deals from suppliers and deliver savings of £2.4 billion back into NHS frontline services by the end of the financial year 2022/23.

The new model consists of eleven specialist buying functions, known as Category Towers, delivering clinical consumables, capital medical equipment and non-medical products such as food and office solutions. Three enabling services for logistics, supporting technology and transactional services underpin the model.

Key benefits the new NHS Supply Chain will bring NHS trusts and suppliers include:

NHS Trusts

  • Savings channelled back to frontline services.
  • Releasing more time for core clinical activities.
  • Greater NHS clinical involvement in purchasing decision.
  • More effective introduction of new products.

Suppliers

  • Lowering sales and marketing costs.
  • Single route into the national market.
  • A joined-up approach across the NHS.
  • Clear route for innovative products.